Supplementary Methods and Materials from ZNF217 Is a Marker of Poor Prognosis in Breast Cancer That Drives Epithelial–Mesenchymal Transition and Invasion
posted on 2023-03-30, 21:01authored byJulie A. Vendrell, Aurélie Thollet, Nhan T. Nguyen, Sandra E. Ghayad, Stéphanie Vinot, Ivan Bièche, Evelyne Grisard, Véronique Josserand, Jean-Luc Coll, Pierre Roux, Laura Corbo, Isabelle Treilleux, Ruth Rimokh, Pascale A. Cohen
PDF file - 107K, complementary information and methods on breast-tumor cohorts, HMLE cells and transcriptomic analysis